Table 3 Mean survival and, 2-, 5-, and 10-year OS of rectal cancer patients (n = 20300)
Variables | Â | Mean survival | 2-year OS | 5-year OS | 10-year OS |
|---|---|---|---|---|---|
T3/4N0M0 | Only surgery | 88.96 M | 71.9% | 59..6% | 41.1% |
Neoadjuvant RT | 115.89 M | 92.3% | 78.1% | 62.2% | |
Adjuvant RT | 111.97 M | 92.4% | 76.7% | 56.8% | |
Surgery + chemo | 117.22 M | 88.7% | 77.3% | 67.3% | |
T1/2N+M0 | Only surgery | 83.81 M | 74.3% | 56.7% | 36.8% |
Neoadjuvant RT | 121.50 M | 93.4% | 81.1% | 69.3% | |
Adjuvant RT | 124.25 M | 94.2% | 83.6% | 68.6% | |
Surgery + chemo | 121.20 M | 91.2% | 81.9% | 66.6% | |
T3/4N+M0 | Only surgery | 54.87 M | 59.3% | 32.5% | 19.4% |
Neoadjuvant RT | 104.47 M | 88.9% | 69.2% | 52.0% | |
Adjuvant RT | 93.94 M | 85.6% | 63.5% | 42.8% | |
Surgery + chemo | 93.62 M | 83.1% | 59.6% | 46.0% |